The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units – A high risk community-hospital interface

    1. Kathy K. Li
    2. Y. Mun Woo
    3. Oliver Stirrup
    4. Joseph Hughes
    5. Antonia Ho
    6. Ana Da Silva Filipe
    7. Natasha Johnson
    8. Katherine Smollett
    9. Daniel Mair
    10. Stephen Carmichael
    11. Lily Tong
    12. Jenna Nichols
    13. Elihu Aranday-Cortes
    14. Kirstyn Brunker
    15. Yasmin A. Parr
    16. Kyriaki Nomikou
    17. Sarah E. McDonald
    18. Marc Niebel
    19. Patawee Asamaphan
    20. Vattipally B Sreenu
    21. David L. Robertson
    22. Aislynn Taggart
    23. Natasha Jesudason
    24. Rajiv Shah
    25. James Shepherd
    26. Josh Singer
    27. Alison H.M. Taylor
    28. Zoe Cousland
    29. Jonathan Price
    30. Jennifer S. Lees
    31. Timothy P.W. Jones
    32. Carlos Varon Lopez
    33. Alasdair MacLean
    34. Igor Starinskij
    35. Rory Gunson
    36. Scott T.W. Morris
    37. Peter C. Thomson
    38. Colin C. Geddes
    39. Jamie P. Traynor
    40. Judith Breuer
    41. Emma C. Thomson
    42. Patrick B. Mark

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Mechanism of duplex unwinding by coronavirus nsp13 helicases

    1. Xiao Hu
    2. Wei Hao
    3. Bo Qin
    4. Zhiqi Tian
    5. Ziheng Li
    6. Pengjiao Hou
    7. Rong Zhao
    8. Sheng Cui
    9. Jiajie Diao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting

    1. Nathan Moore
    2. Rebecca Williams
    3. Matilde Mori
    4. Beatrice Bertolusso
    5. Gabrielle Vernet
    6. Jessica Lynch
    7. Pete Philipson
    8. Thomas Ledgerwood
    9. Stephen P Kidd
    10. Claire Thomas
    11. Veronica Garcia-Arias
    12. Michelle Young
    13. Kordo Saeed
    14. Kirsty Gordon
    15. Nicholas Cortes

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Companionship for women/birthing people using antenatal and intrapartum care in England during COVID-19: a mixed-methods analysis of national and organisational responses and perspectives

    1. Gill Thomson
    2. Marie-Claire Balaam
    3. Rebecca Nowland (Harris)
    4. Nicola Crossland
    5. Gill Moncrieff
    6. Stephanie Heys
    7. Arni Sarian
    8. Joanne Cull
    9. Anastasia Topalidou
    10. Soo Downe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Using Google Health Trends to investigate COVID-19 incidence in Africa

    1. Alexander Fulk
    2. Daniel Romero-Alvarez
    3. Qays Abu-Saymeh
    4. Jarron M. Saint Onge
    5. A. Townsend Peterson
    6. Folashade B. Agusto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. When can we safely return to normal? A novel method for identifying safe levels of NPIs in the context of COVID-19 vaccinations

    1. Gianluca Bianchin
    2. Emiliano Dall’Anese
    3. Jorge I. Poveda
    4. Andrea G. Buchwald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells

    1. Adam Pickard
    2. Ben C. Calverley
    3. Joan Chang
    4. Richa Garva
    5. Sara Gago
    6. Yinhui Lu
    7. Karl E. Kadler

    Reviewed by Review Commons, ScreenIT

    7 evaluationsAppears in 2 listsLatest version Latest activity

  8. Reportable range of quantitative assays for SARS-CoV-2 antibodies determination: An overlooked issue?

    1. Ruggero Dittadi
    2. Isabella Bertoli
    3. Paolo Carraro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants

    1. Jianliang Xu
    2. Kai Xu
    3. Seolkyoung Jung
    4. Andrea Conte
    5. Jenna Lieberman
    6. Frauke Muecksch
    7. Julio Cesar Cetrulo Lorenzi
    8. Solji Park
    9. Zijun Wang
    10. Lino Tessarollo
    11. Tatsiana Bylund
    12. Gwo-Yu Chuang
    13. Adam S. Olia
    14. Tyler Stephens
    15. I-Ting Teng
    16. Yaroslav Tsybovsky
    17. Tongqing Zhou
    18. Theodora Hatziioannou
    19. Paul D. Bieniasz
    20. Michel C. Nussenzweig
    21. Peter D. Kwong
    22. Rafael Casellas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study

    1. Jose Morgenstern
    2. Jose N Redondo
    3. Alvaro Olavarria
    4. Isis Rondon
    5. Santiago Roca
    6. Albida De Leon
    7. Juan Canela
    8. Johnny Tavares
    9. Miguelina Minaya
    10. Oscar Lopez
    11. Ana Castillo
    12. Ana Placido
    13. Rafael Cruz
    14. Yudelka Merette
    15. Marlenin Toribio
    16. Juan Francisco

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    3 evaluationsAppears in 2 listsLatest version Latest activity
Newer Page 2219 of 2361 Older